i-SENS Inc (099190) - Total Liabilities

Latest as of March 2026: ₩234.55 Billion KRW ≈ $158.95 Million USD

Based on the latest financial reports, i-SENS Inc (099190) has total liabilities worth ₩234.55 Billion KRW (≈ $158.95 Million USD) as of March 2026. Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities. Explore i-SENS Inc long-term investment intensity to see how much of total assets are deployed in long-term investments.

i-SENS Inc - Total Liabilities Trend (2012–2025)

This chart illustrates how i-SENS Inc's total liabilities have evolved over time, based on quarterly financial data. For the complete balance sheet picture, see 099190 asset base.

i-SENS Inc Competitors by Total Liabilities

The table below lists competitors of i-SENS Inc ranked by their total liabilities.

Company Country Total Liabilities
Paxman AB
ST:PAX
Sweden Skr59.89 Million
Alicanto Minerals Ltd
AU:AQI
Australia AU$692.69K
Mycenax Biotech
TWO:4726
Taiwan NT$1.69 Billion
T&L Co. Ltd
KQ:340570
Korea ₩20.08 Billion
Hope Education Group Co. Ltd
F:HE1
Germany €8.01 Billion
Wanhwa Enterprise Co
TW:2701
Taiwan NT$1.39 Billion
Seoul City Gas
KO:017390
Korea ₩437.20 Billion
Southern Petrochemicals Industries Corporation Limited
NSE:SPIC
India Rs-13.70 Billion

Liability Composition Analysis (2012–2025)

This chart breaks down i-SENS Inc's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted. See 099190 net asset quality index to measure how much of total assets are equity-financed.

Liquidity & Leverage Metrics

Key Metrics Explained

Metric Value Description
Current Ratio 1.73 Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities)
Quick Ratio N/A More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities)
Cash Ratio N/A Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities)
Debt to Equity 0.70 Measures financial leverage (Total Liabilities ÷ Shareholder Equity)
Debt to Assets 0.40 Portion of assets financed with debt (Total Liabilities ÷ Total Assets)

Liability Trends Comparison

This chart compares key liability metrics across different time periods, showing how i-SENS Inc's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.

Annual Total Liabilities for i-SENS Inc (2012–2025)

The table below shows the annual total liabilities of i-SENS Inc from 2012 to 2025.

Year Total Liabilities Change
2025-12-31 ₩239.34 Billion
≈ $162.20 Million
-3.45%
2024-12-31 ₩247.89 Billion
≈ $167.99 Million
+26.91%
2023-12-31 ₩195.32 Billion
≈ $132.37 Million
+19.27%
2022-12-31 ₩163.76 Billion
≈ $110.98 Million
+1.81%
2021-12-31 ₩160.85 Billion
≈ $109.00 Million
+83.75%
2020-12-31 ₩87.54 Billion
≈ $59.32 Million
+22.46%
2019-12-31 ₩71.48 Billion
≈ $48.44 Million
+0.50%
2018-12-31 ₩71.12 Billion
≈ $48.20 Million
-0.22%
2017-12-31 ₩71.28 Billion
≈ $48.31 Million
+9.00%
2016-12-31 ₩65.39 Billion
≈ $44.32 Million
+36.87%
2015-12-31 ₩47.78 Billion
≈ $32.38 Million
+6.88%
2014-12-31 ₩44.70 Billion
≈ $30.29 Million
+20.50%
2013-12-31 ₩37.10 Billion
≈ $25.14 Million
+57.12%
2012-12-31 ₩23.61 Billion
≈ $16.00 Million
--

About i-SENS Inc

KQ:099190 Korea Healthcare Equipment & Supplies
Market Cap
$147.56 Million
₩217.73 Billion KRW
Market Cap Rank
#17814 Global
#749 in Korea
Share Price
₩15850.00
Change (1 day)
-0.38%
52-Week Range
₩14690.00 - ₩27000.00
All Time High
₩38452.83
About

i-SENS, Inc. provides diagnostic biosensors in South Korea. The company offers point of care testing devices, such as HbA1c, blood gas, electrolyte, and PT/INR analyzers; CareSens blood glucose monitoring systems; and lancing and other ancillary devices, as well as diabetes management services. It exports its products to approximately 110 countries, including the United States, Japan, and Europe.… Read more